Patients suffering from pneumonia due to SARS-CoV-2 infection, after admission to the Intensive Care Unit (ICU), are susceptible to development of various functional sequelae, increased risk of chronic diseases, increased mortality rates and existence of relevant impacts on their quality of life in the months and years that follow the ICU admission. The present study aims to assess the determinants of health-related quality of life and patient-centered long-term outcomes among patients recovered from SARS-COV-2 pneumonia, after discharge from the ICU, its determinants and predictors, in Portugal. It is a multicenter prospective cohort study of adult patients admitted at the ICU due to proven or suspected SARS-CoV-2 infection, included 90 days after discharge from the ICU. The primary outcome is one-year health-related quality of life assessed by the EQ-5D-3L. The secondary outcomes are all-cause mortality, rehospitalizations, return to work or study, the degree of dependence and functional capacity, symptoms of anxiety, depression and post-traumatic stress, level of physical activity and cognitive, renal and respiratory functions after ICU discharge. Investigators will collect data by means of structured telephone interviews, at a 12 months follow up period.

Inclusion Criteria:

• Men and women aged 18 years and older
• Admission to the intensive care unit (ICU)
• Pneumonia due to proven or suspected SARS-CoV-2 infection

Exclusion Criteria:

• Refusal to provide consent for the study by the patient or legal guardian
• ICU length of stay less than 24 hours
• Absence of telephone contact

Adult survivors of ICU admission and pneumonia due to proven or suspected SARS-CoV-2 infection.

The authors encourage interested parties to contact the corresponding author with data sharing requests, including for access to additional unpublished data.